Skip to main content
SpringerLink
Log in

Antineoplastics

Lack of efficacy and various toxicities following off-label use: 26 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Luger AL, et al. Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis. Journal of Neuro-Oncology 159: 243-259, No. 2, Sep 2022. Available from: URL: http://doi.org/10.1007/s11060-022-04049-w

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1950, 47 (2023). https://doi.org/10.1007/s40278-023-36444-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-36444-9

Search

Navigation